首页> 美国卫生研究院文献>other >Guidelines on Good Clinical Laboratory Practice
【2h】

Guidelines on Good Clinical Laboratory Practice

机译:良好临床检验规范指南

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A set of Good Clinical Laboratory Practice (GCLP) standards that embraces both the research and clinical aspects of GLP were developed utilizing a variety of collected regulatory and guidance material. We describe eleven core elements that constitute the GCLP standards with the objective of filling a gap for laboratory guidance, based on IND sponsor requirements, for conducting laboratory testing using specimens from human clinical trials. These GCLP standards provide guidance on implementing GLP requirements that are critical for laboratory operations, such as performance of protocol-mandated safety assays, peripheral blood mononuclear cell processing and immunological or endpoint assays from biological interventions on IND-registered clinical trials. The expectation is that compliance with the GCLP standards, monitored annually by external audits, will allow research and development laboratories to maintain data integrity and to provide immunogenicity, safety, and product efficacy data that is repeatable, reliable, auditable and that can be easily reconstructed in a research setting.
机译:利用各种收集的监管和指导材料,开发了一套涵盖GLP研究和临床方面的良好临床实验室规范(GCLP)标准。我们描述了构成GCLP标准的11个核心要素,目的是根据IND发起者的要求填补用于实验室指导的空白,以便使用人类临床试验的标本进行实验室测试。这些GCLP标准为实施GLP要求提供了指导,这些要求对于实验室操作至关重要,例如执行协议规定的安全性测定,外周血单核细胞加工以及来自IND注册的临床试验的生物干预的免疫学或终点测定。期望遵守GCLP标准并由外部审核每年进行监督,这将使研发实验室能够保持数据完整性,并提供可重复,可靠,可审核且易于重建的免疫原性,安全性和产品功效数据在研究环境中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号